CD19 and bacterial infectious disease: Unfortunately, patient 3 still suffered from multiple severe infections within 49 days after CD19 CAR-T cell infusion, mainly manifested as bacterial infections, including Klebsiella pneumoniae and Pseudomonas aeruginosa.